Abstract
IL-17 is a novel cytokine that is characterized by an ability to induce several types of cells to secrete proinflammatory cytokines in various inflammatory diseases. This study analyzed the influence of IL-17F gene polymorphisms on disease susceptibility and clinical features. Ninety-nine Behçet’s disease (BD) patients and 114 controls were genotyped to analyze three single nucleotide polymorphisms (SNPs) including A126G, G155A, and A161G of the IL-17F gene using automated sequencing. We compared the frequencies of IL-17F alleles, genotypes, and haplotypes in patients with BD and controls using the chi-square or Fisher’s exact test. Significant differences in the frequencies of allele and genotype in A126G SNP of IL-17 gene were found between BD patients and controls (P < 0.001 and P < 0.001, respectively). None of three IL-17F SNPs were associated with diverse clinical features in BD. The frequency of haplotype AA did not differ between patients with BD and controls (P = 0.985). The haplotypes, AG, and GG, have positive and inverse association with BD susceptibility (P < 0.001 and P < 0.001, respectively). These findings suggest that IL-17 gene SNPs may influence the susceptibility of BD.
Similar content being viewed by others
References
Sakane T, Takeno M, Suzuki N, Inaba G (1999) Behcet’s disease. N Engl J Med 341:1284–1291. doi:10.1056/NEJM199910213411707
Fresko I, Soy M, Hamuryudan V, Yurdakul S, Yavuz S, Tumer Z et al (1998) Genetic anticipation in Behcet’s syndrome. Ann Rheum Dis 57:45–48
Yokota K, Oguma K (1997) IgA protease produced by Streptococcus sanguis and antibody production against IgA protease in patients with Behcet’s disease. Microbiol Immunol 41:925–931
Itoh R, Takenaka T, Okitsu-Negishi S, Matsushima K, Mizoguchi M (1994) Interleukin 8 in Behcet’s disease. J Dermatol 21:397–404
Adam B, Calikoglu E (2004) Serum interleukin-6, procalcitonin and C-reactive protein levels in subjects with active Behcet’s disease. J Eur Acad Dermatol Venereol 18:318–320. doi:10.1111/j.1468-3083.2004.00907.x
Evereklioglu C, Er H, Turkoz Y, Cekmen M (2002) Serum levels of TNF-α, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behcet’s disease. Mediators Inflamm 11:87–93. doi:10.1080/09629350220131935
Musabak U, Pay S, Erdem H, Simsek I, Pekel A, Dinc A et al (2006) Serum interleukin-18 levels in patients with Behcet’s disease. Is its expression associated with disease activity or clinical presentations? Rheumatol Int 26:545–550. doi:10.1007/s00296-005-0029-8
Kawaguchi M, Adachi M, Oda N, Kokubu F, Huang SK (2004) IL-17 cytokine family. J Allergy Clin Immunol 114:1265–1273. doi:10.1016/j.jaci.2004.10.019
Moseley TA, Haudenschild DR, Rose L, Reddi AH (2003) Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev 14:155–174. doi:10.1016/S1359-6101(03)00002-9
Chabaud M, Lubberts E, Joosten L, van Den Berg W, Miossec P (2001) IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis. Arthritis Res 3:168–177. doi:10.1186/ar294
Kurasawa K, Hirose K, Sano H, Endo H, Shinkai H, Nawata Y et al (2000) Increased interleukin-17 production in patients with systemic sclerosis. Arthritis Rheum 43:2455–2463. doi :10.1002/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K
Wong CK, Ho CY, Li EK, Lam CW (2000) Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus 9:589–593. doi:10.1191/096120300678828703
Honorati MC, Bovara M, Cattini L, Piacentini A, Facchini A (2002) Contribution of interleukin 17 to human cartilage degradation and synovial inflammation in osteoarthritis. Osteoarthritis Cartilage 10:799–807. doi:10.1053/joca.2002.0829
Hamzaoui K, Hamzaoui A, Guemira F, Bessioud M, Hamza M, Ayed K (2002) Cytokine profile in Behcet’s disease patients Relationship with disease activity. Scand J Rheumatol 31:205–210. doi:10.1080/030097402320318387
International Study Group for Behçet’s disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080
Chang HK, Cheon KS (2002) The clinical significance of a pathergy reaction in patients with Behçet’s disease. J Korean Med Sci 17:371–374
Chang HK, Kim JU, Cheon KS, Chung HR, Lee KW, Lee IH (2001) HLA-B51 and its allelic types in association with Behçet’s disease and recurrent aphthous stomatitis in Korea. Clin Exp Rheumatol 19(Suppl 24):S31–S35
Jung HY, Park JS, Park YJ, Kim YJ, Kimm K, Koh IS (2004) HapAnalyzer: minimum haplotype analysis system for association studies. Genomics Inf 2:107–109
Park K, Kim N, Nam J, Bang D, Lee ES (2006) Association of TNFA promoter region haplotype in Behcet’s disease. J Korean Med Sci 21:596–601. doi:10.3346/jkms.2006.21.4.596
Lee EB, Kim JY, Zhao J, Park MH, Song YW (2007) Haplotype association of IL-8 gene with Behcet’s disease. Tissue Antigens 69:128–132. doi:10.1111/j.1399-0039.2006.00736.x
Jang WC, Park SB, Nam YH, Lee SS, Kim JW, Chang IS et al (2005) Interleukin-18 gene polymorphisms in Korean patients with Behcet’s disease. Clin Exp Rheumatol 23(Suppl 38):S59–S63
Chang HK, Jang WC, Park SB, Han SM, Nam YH, Lee SS et al (2005) Association between interleukin 6 gene polymorphisms and Behcet’s disease in Korean people. Ann Rheum Dis 64:339–340. doi:10.1136/ard.2004.024208
Chi W, Zhu X, Yang P, Liu X, Lin X, Zhou H et al (2008) Upregulated IL-23 and IL-17 in Behçet patients with active uveitis. Invest Ophthalmol Vis Sci 49:3058–3064. doi:10.1167/iovs.07-1390
Kawaguchi M, Takahashi D, Hizawa N, Suzuki S, Matsukura S, Kokubu F et al (2006) IL-17F sequence variant (His161Arg) is associated with protection against asthma and antagonizes wild-type IL-17F activity. J Allergy Clin Immunol 117:795–801. doi:10.1016/j.jaci.2005.12.1346
Southam L, Heath O, Chapman K, Loughlin J (2006) Association analysis of the interleukin 17 genes IL17A and IL17F as potential osteoarthritis susceptibility loci. Ann Rheum Dis 65:556–557. doi:10.1136/ard.2005.045922
Ramsey CD, Lazarus R, Camargo CA Jr, Weiss ST, Celedon JC (2005) Polymorphisms in the interleukin 17F gene (IL17F) and asthma. Genes Immun 6:236–241. doi:10.1038/sj.gene.6364170
Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM et al (2005) Interleukin 17-producing CD4 + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6:1123–1132. doi:10.1038/ni1254
Ferretti S, Bonneau O, Dubois GR, Jones CE, Trifilieff A (2003) IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. Immunol 170:2106–2112
Chakir J, Shannon J, Molet S, Fukakusa M, Elias J, Laviolette M et al (2003) Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-β, IL-11, IL-17, and type I and type III collagen expression. J Allergy Clin Immunol 111:1293–1298. doi:10.1067/mai.2003.1557
Witowski J, Ksiazek K, Jorres A (2004) Interleukin-17: a mediator of inflammatory responses. Cell Mol Life Sci 61:567–579. doi:10.1007/s00018-003-3228-z
Hymowitz SG, Filvaroff EH, Yin JP, Lee J, Cai L, Risser P et al (2001) IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. EMBO J 20:5332–5341. doi:10.1093/emboj/20.19.5332
Saruhan-Direskeneli G, Yentur SP, Akman-Demir G, Isik N, Serdaroglu P (2003) Cytokines and chemokines in neuro-Behcet’s disease compared to multiple sclerosis and other neurological diseases. J Neuroimmunol 145:127–134. doi:10.1016/j.jneuroim.2003.08.040
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jang, WC., Nam, YH., Ahn, YC. et al. Interleukin-17F gene polymorphisms in Korean patients with Behçet’s disease. Rheumatol Int 29, 173–178 (2008). https://doi.org/10.1007/s00296-008-0664-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-008-0664-y